Aimovig

News

NICE rejects Novartis’ migraine prevention drug Aimovig

Some migraine sufferers in the UK hoping to get access to Novartis’ new migraine prevention drug Aimovig are facing disappointment after NICE rejected it in draft guidance.

News

Breakthrough migraine prevention treatment approved in Europ...

Novartis’ Aimovig (erenumab) has been approved by the European Medicines Agency (EMA) making it first self-administered, monthly migraine prevention jab available for adult patients in Euro

News

Migraine prevention drug Aimovig poised for EU approval

The first antibody treatment to prevent migraine (Aimovig), produced by Novartis, is on the cusp of approval.

NICE rejects Novartis’ migraine prevention drug Aimovig

Breakthrough migraine prevention treatment approved in Europ...

Migraine prevention drug Aimovig poised for EU approval

Setback for MSD as German court blocks Keytruda SC launch

How to meet your physicians where they are online

Editor's Picks